FountainBlue's Life Science Entrepreneurs' Forum: Accelerating BioPharma Development August 17, 2009

Accelerating BioPharma Development
Life science professionals are faced with the usual challenges in developing, testing, manufacturing, approving and distributing biopharma solutions from drug discovery to therapeutics to enabling platforms. These unique challenges extend the time from inception to market, yet the companies that successfully navigate these challenges are companies to watch – bringing financial returns to companies, and products and services to markets.

With the dramatic and rapid changes in policy and administration and outlook toward the life science industry overall, new interest has been placed on how to identify the key players in the biopharma market, and facilitate forward progress for people and organizations in this industry. This month’s panel will address today’s unique challenges and share successes worth noting.
• Facilitator Peter Berger II, CEO, Alitora
• Panelist Ian Irwin, Director of Drug Discovery, Parkinson’s Institute
• Panelist Michael O’Donnell, Partner, Wilson Sonsini
• Panelist Ted Spack, Senior Director of Business Development, SRI International
• Panelist Nandini Tandon, Managing Director, Lumira Capital
• Presenting Entrepreneur: Yadon Arad, Tiara Pharmaceuticals
• Presenting Entrepreneur: Julia O’Connor, CEO, Accelalox Inc.
• Presenting Entrepreneur: David Zarling, CEO, Colby Pharmaceuticals

Audience: Entrepreneurs, intrapreneurs and investors, no service providers please
More information is available at http://www.svlifescience.com.

Official Website: http://www.svlifescience.com